SCHEMBL29800055

SCHEMBL29800055

CC(=O)N(Cc1ccccc1)c1sc2c(Cl)c(O)ccc2c1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TSPO P30536 2/20 0.40
▸ DYRK1A Q13627 1/20 0.38
▸ KMT2A Q03164 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ NPC1 O15118 3/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ PAX8 Q06710 2/20 0.36
▸ GLA P06280 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ LTB4R2 Q9NPC1 1/20 0.36
▸ NR1H4 Q96RI1 1/20 0.36
▸ STAT3 P40763 1/20 0.35
▸ RNF4 P78317 1/20 0.34
▸ BCL2L1 Q07817 2/20 0.34
▸ MCL1 Q07820 2/20 0.34
▸ JAK2 O60674 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24682198 1.00 TSPO (0.40) TSPODYRK1AKMT2AMEN1L3MBTL1
SCHEMBL24683203 0.91 HSP90AA1 (0.39) TSPODYRK1AKMT2AMEN1L3MBTL1
SCHEMBL29799821 0.91 HSP90AA1 (0.39) TSPODYRK1AKMT2AMEN1L3MBTL1
SCHEMBL29799918 0.90 KMT2A (0.45) TSPOKMT2AMEN1NPC1RAB9A
SCHEMBL24683204 0.90 KMT2A (0.45) TSPOKMT2AMEN1NPC1RAB9A
SCHEMBL24683226 0.89 PDK1 (0.37) TSPODYRK1AKMT2AMEN1L3MBTL1
SCHEMBL29800012 0.89 PDK1 (0.37) TSPODYRK1AKMT2AMEN1L3MBTL1
SCHEMBL24683887 0.89 CA12 (0.37) TSPODYRK1AKMT2AMEN1L3MBTL1
SCHEMBL24683802 0.89 NR1H4 (0.36) TSPODYRK1AKMT2AMEN1L3MBTL1
SCHEMBL29800082 0.89 NR1H4 (0.36) TSPODYRK1AKMT2AMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY OTCPHARM JSC (RU) 2024-05-30 — — US disclosed
EP-4293017-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Otcpharm JSC (RU) 2023-12-20 — — EP disclosed
CN-117222630-A 2-acetamido-6-hydroxy-benzothiophene derivatives having antiviral activity OTC制药公司(JSC) 2023-12-12 — — CN disclosed
WO-2022173329-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Акционерное общество "Отисифарм" 2022-08-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY ACE2, ACE, EIF2AK2 TSPO 4234/4885DYRK1A 4139/4885KMT2A 734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback